国内首个患者智能匹配专利技术落地，翼帆医药重构临床药物试验招募逻辑

Core Viewpoint - Waterdrop Group's subsidiary, Beijing Yifan Fengshun Pharmaceutical Technology Co., Ltd., has developed a patented "Intelligent Patient Matching Technology" for clinical drug trials, addressing inefficiencies in patient recruitment [1][2]. Group 1: Technology Overview - The newly patented technology utilizes a dual-track approach of "numerical matching + semantic embedding matching" to achieve precise patient-trial project matching [2]. - The system disaggregates patient information into numerical data (e.g., age, lab results) and clinical history, while also breaking down trial inclusion/exclusion criteria into corresponding numerical and descriptive information [2]. - The technology boasts three core advantages: a 300% increase in recruitment efficiency, over 92% accuracy in matching, and strong adaptability to various data formats and trial criteria [2]. Group 2: Industry Impact - The application of this technology is expected to save pharmaceutical companies significant time and labor costs in patient recruitment, while also connecting eligible patients with high-quality clinical trial resources [3]. - The technology has been piloted in multiple top-tier hospitals and pharmaceutical companies, successfully matching nearly 1,000 patients and helping clinical trial projects meet recruitment goals 3-6 months ahead of schedule [3]. - Yifan Pharmaceutical focuses on addressing the industry pain points of slow recruitment and difficult matching, leveraging Waterdrop's extensive patient base and digital capabilities to enhance research efficiency for renowned pharmaceutical companies [3].